All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

How can patient-reported QoL change our view on unmet needs in GvHD?

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Nada Hamad, St Vincent's Hospital, Sydney, AU and Silvy Lachance, Maisonneuve-Rosemont Hospital, Montreal, CA. We asked, How can patient-reported QoL change our view on unmet needs in GvHD?

How can patient-reported QoL change our view on unmet needs in GvHD?

The main topic of this podcast revolves around documenting the quality of life (QoL) of patients with acute and chronic GvHD. Lachance focused her part of the talk on patient-reported outcomes regarding the impact GvHD has on aspects of their daily life. Research demonstrated that GvHD severity, long term corticoid treatment or being corticoid resistant have a significant impact on QoL.

Hamad continues the conversation by exploring the stress of survival for patients undergoing bone marrow transplantation. She believes that patient self-reported symptoms should direct future research on GvHD treatment and prevention. 

 

Share: